McCamish Mark Anthony
- SEC CIK
- 0001390798
No open-market purchases or sales filed in the past year.
Current role at each company
- AVDL Avadel Pharmaceuticals PLCDirectoras of Feb 12, 2026
- RFL Rafael Holdings, Inc.Directoras of Jan 8, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists McCamish Mark Anthony as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AVDL Avadel Pharmaceuticals PLC
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 29, 2023 (view filing) | Dec 28 | 1 day | McCamish Mark AnthonyDirector | SSaleADSs | −75.0K | $14.53 | −$1.09M | −52.8%67.0K after | 10b5-1 |
| Aug 15, 2023 (view filing) | Aug 11 | 4 days | McCamish Mark AnthonyDirector | SSaleADSs | −29.0K | $14.93 | −$432.6K | −16.9%142.0K after |